Prevalence, Immunotherapy Use in Anorectal Mucosal Melanoma Found to Be Increasing
A retrospective study identified incidence of and treatment trends for anorectal mucosal melanoma tumors.
Skin Cancer
Incidence, Site of Pediatric Melanoma Different Among Male and Female Adolescents and Young Adults
Researchers in Colorado reviewed data on melanoma in pediatric patients 10 to 19 years, finding sex-specific differences in anatomic site and incidence of the disease.
Misdiagnosed Wart Highlights Importance of Obtaining Biopsy of Changing Skin Lesions
Patients who present with irregular or growing amelanocytic lesions on the acral surface of the hands or feet should undergo biopsy promptly.
Melanoma Treatment Regimens
View treatment regimens for melanoma, including guidance on options and dosing for a number of drugs including ipilimumab and dacarbazine.
Primary Histologic Subtype an Independent Predictor of Survival in Melanoma
A comparison study of the tumor molecular profiles of NM and SSM sought to explain the distinctly different prognoses among patients with either of these 2 histologic subtypes.
Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
Results of a retrospective chart review of patients with BRAF-mutant metastatic melanoma receiving sequential treatment with immunotherapy and targeted therapy or vice versa are presented.
Number of Cutaneous Nevi Associated With Mortality Risk in Melanoma, Particularly for Men
An epidemiologic study shows that the number of cutaneous nevi may be a better independent predictor of melanoma death in men compared with women.
Melanoma Survival Varies Among U.S. States
The number of physicians in a state and melanoma incidence were factors in melanoma mortality, researchers found.
Presence of Genetic Variants Not Always Predictive of Cancer Risk
Researchers investigating genotype-phenotype relationships found that clinical manifestations of some diseases do not match the incidence of genetic variants that predict disease risk.
Risk High, Prognosis Poor for Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
A retrospective study identifies prognoses and risk factors for SCC among solid organ transplant recipients.
Next post in Skin Cancer
